Skip to main content

Table 1 Patient and tumour characteristics

From: Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer

  

CEAwatch

Usual care

P

Total (N)

 

184

61

NA

Male (% )

 

109 (59)

28 (60)

ns

Median age (range)

 

67.0 (38-87)

70.5 (50-88)

ns

Comorbidity (%)

Major

20 (11)

14 (25)

0.006

 

Minor/None

164 (89)

46 (75)

 

pT (%)

0, 1, or 2

62 (33)

13 (21)

ns

 

3 or 4

121 (66)

47 (77)

 
 

unknown

1 (1)

1 (2)

 

pN (%)

0

119 (65)

32 (52)

ns

 

1 or 2

65 (35)

29 (48)

 

Location (%)

Colon

98 (53)

44 (72)

0.009

 

Rectum

86 (47)

17 (28)

 
  1. NA = not applicable, ns = not significant